Recombinant Human FLT3 Ligand Protein

SKU:BHP22200010
Research Validated
Overview
Click light‑blue chips for details
Recombinant human FLT3 Ligand (FLT3L) expressed in human cells as a glycosylated, tag-free and carrier-free monomer. Animal-free and xeno-free, with >95% purity by SDS-PAGE. Used for hematopoietic stem/progenitor-cell culture with SCF and TPO, dendritic-cell research, hPSC-derived immune-cell differentiation and FLT3/CD135 signaling studies.
Expression System Human cells
Tag Tag-free
Purity >95% by SDS-PAGE
Species Human
Form Lyophilized
Molecular Weight 24–30 kDa
Biological Activity OCI-AML5 cell proliferation
Options selector
Catalog no. Size
HHM-FT-0010 10 ug
HHM-FT-0100 100 ug
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Size: 10 ug, 100 ug
  • Lead time: options listed in "Availability Content"; other statuses may take longer.
  • Storage: As supplied: −20°C to −80°C for up to 12 months from receipt. After reconstitution: 2°C to 8°C for up to 1 month, or −20°C to −80°C for up to 3 months, under sterile conditions. Avoid repeated freeze–thaw cycles.
  • Shipping: Please contact us to confirm shipping conditions for this product.
  • Upon receipt: store at recommended temperature as soon as possible.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Target FLT3 Ligand
Alternative names FLT3L; Flt3 Ligand; FLT3-Ligand
Species Human
Applications
  • Stem Cell Differentiation
  • Immunotherapy
  • Hematopoietic Differentiation
  • Cell Proliferation
  • Colony-Forming Unit Assay
  • Cell Signaling Studies
Tag Tag-free
Expression system
  • Human cells
Expression region Full length
Molecular weight 24–30 kDa
Purity >95% by SDS-PAGE
Biological activity Biological activity of StemImmune Recombinant Human FLT3-Ligand is demonstrated by dose-dependent stimulation of proliferation in human OCI-AML5 cells.
Endotoxin level <0.5 EU/µg
Animal origin-free Animal-free / Xeno-free
Reconstitution Briefly centrifuge the vial before opening. Reconstitute in sterile PBS containing 0.1% endotoxin-free recombinant human serum albumin.
Formulation Lyophilized from a 0.2 µm-filtered solution in PBS without carrier protein
Form Lyophilized
Storage As supplied: −20°C to −80°C for up to 12 months from receipt. After reconstitution: 2°C to 8°C for up to 1 month, or −20°C to −80°C for up to 3 months, under sterile conditions. Avoid repeated freeze–thaw cycles.
Catalog no. (Mfr.) HHM-FT-0010 | HHM-FT-0100
Main SKU BHP22200010
Recombinant Protein · Cytokine

Product Overview

Recombinant Human FLT3 Ligand Protein (FLT3L) is a hematopoietic cytokine expressed in human cells and supplied as a glycosylated monomer. It is tag-free, animal-free and xeno-free, and is lyophilized from a 0.2 µm-filtered PBS solution without carrier protein, with purity >95% by SDS-PAGE and endotoxin <0.5 EU/µg.

FLT3 Ligand is used in hematopoietic stem/progenitor-cell culture, usually together with SCF and TPO, in dendritic-cell development and in staged differentiation of immune cells from pluripotent stem cells, as well as in FLT3/CD135 signaling studies. Expression in human cells supports mammalian folding and glycosylation, and five peer-reviewed studies identify this FLT3 Ligand or its catalog number.

Expression system: Human cells · Tag-free · Animal-free

Scientific Background

FLT3 Ligand is a glycoprotein cytokine produced by several stromal and immune-cell populations. The soluble form is released from a membrane-associated precursor and binds the receptor tyrosine kinase FLT3/CD135 on early hematopoietic progenitors.

Receptor activation engages PI3K–AKT, RAS–MAPK and STAT signaling, and the result depends on progenitor state and companion cytokines. FLT3L acts most clearly on early progenitors and dendritic-cell lineages, and is studied with SCF and TPO in HSPC culture and with stage-specific signals in dendritic, lymphoid and other immune-cell differentiation.

Research Applications

FLT3 Ligand is mostly used in combination with other cytokines to support FLT3-positive early progenitors and dendritic-cell lineages. The table shows typical placements; it is a planning guide, not a universal protocol.

Application Role of FLT3 Ligand Companion context Suggested readouts
Cord-blood or adult CD34+ HSPC culture Survival and expansion of early progenitors SCF and TPO, plus protocol-dependent signals Cell count, viability, CD34/CD38/CD90, CFU and engraftment assays
hPSC hematopoietic differentiation Support after hemogenic/endothelial stages SCF, TPO, IL-3, IL-7 and/or Notch context CD43, CD45, CD34, lineage markers and functional assays
Dendritic-cell research Expansion of FLT3-responsive progenitors Lineage-specific maturation signals DC subset markers, antigen presentation and cytokine output
FLT3 signaling assay Receptor stimulation Defined serum-reduced or basal system Phospho-FLT3, ERK, AKT, STAT5 and proliferation

Planning considerations

  • Define the developmental or immune-cell stage and confirm that the target population expresses FLT3/CD135 or depends on the pathway.
  • Take the starting dose from published or in-house qualified work and titrate it for each cell source, basal medium and readout; no universal working concentration or EC50 applies across systems.
  • Control timing and companion cytokines, since signal order, duration and pathway interactions shape the outcome.
  • Include no-factor, vehicle and pathway-response controls, and assess identity, viability, signaling and function rather than cell number alone.

Protein Specifications

Target FLT3 Ligand
Alternative names FLT3L; Flt3 Ligand; FLT3-Ligand
Species Human
Expression system Human cells
Structure Glycosylated monomer
Protein family Hematopoietic cytokine
Tag Tag-free
Animal origin Animal-free / Xeno-free
Molecular weight 24–30 kDa. Refer to the lot-specific Certificate of Analysis (CoA) for lot data.
Purity >95% by SDS-PAGE
Endotoxin level <0.5 EU/µg
Formulation Lyophilized from a 0.2 µm-filtered solution in PBS without carrier protein
Form Lyophilized
Biological activity Proliferation of human OCI-AML5 cells
Applications Stem Cell Differentiation, Immunotherapy, Hematopoietic Differentiation, Cell Proliferation, Colony-Forming Unit Assay, Cell Signaling Studies

Biological Activity & Quality Control

Biological activity is shown by dose-dependent stimulation of proliferation in human OCI-AML5 cells.

Lot-specific activity and purity data are provided on the Certificate of Analysis (CoA), available from BioHippo on request.

Reconstitution

  1. Briefly centrifuge the vial before opening.
  2. Reconstitute in sterile PBS containing 0.1% endotoxin-free recombinant human serum albumin.
  3. Mix gently and prepare single-use aliquots under sterile conditions.
  4. Avoid repeated freeze–thaw cycles.

Storage & Shipping

Storage As supplied: −20°C to −80°C for up to 12 months from receipt. After reconstitution: 2°C to 8°C for up to 1 month, or −20°C to −80°C for up to 3 months, under sterile conditions. Avoid repeated freeze–thaw cycles.
Shipping Please contact us to confirm shipping conditions for this product.

Selected References

  1. Hannum C, Culpepper J, Campbell D, et al. (1994) Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368:643-648. 10.1038/368643a0
  2. Savvides SN, Boone T, Andrew Karplus P (2000) Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots. Nat Struct Biol 7:486-491. 10.1038/75896

Safety & Handling

Handle as a laboratory reagent and consult the linked SDS before use. Avoid repeated freeze–thaw cycles of the reconstituted protein.

For research use only. Not for diagnostic or therapeutic use.

Q.What is FLT3 Ligand used for?
A.Typical uses are culture of hematopoietic stem and progenitor cells, studies of dendritic-cell development, differentiation of immune cells from hPSCs and analysis of FLT3/CD135 signaling.
Q.Which cytokines are commonly combined with FLT3 Ligand?
A.In HSPC culture it is usually paired with SCF and TPO. Depending on the target lineage and stage, an IL-3, IL-7 or IL-15 signal, or Notch-related signals, can be added.
Q.Which expression system is used?
A.The protein is made in human cells and supplied as a glycosylated monomer, tag-free and in an animal-free, xeno-free format, with purity above 95% by SDS-PAGE and endotoxin below 0.5 EU/µg.
Q.How is biological activity tested?
A.Activity is measured by dose-dependent stimulation of human OCI-AML5 cell proliferation. No numerical EC50 is given by the manufacturer; refer to the lot-specific Certificate of Analysis.
Q.How is FLT3 Ligand reconstituted?
A.Spin the vial down briefly and dissolve the powder in sterile PBS containing 0.1% endotoxin-free recombinant human serum albumin. Store in aliquots so that the protein is not frozen and thawed repeatedly.
Q.Is this product for clinical use?
A.No. It is a research-use-only reagent and must not be used for diagnostic or therapeutic purposes.

Can't Find What You're Looking For? We can help you source the best match or customize a recombinant protein solution for your study. Options may include species (human/mouse/rat), protein region/domain (full-length vs fragment), tag or label (His/GST/FLAG/biotin/fluorescent), expression system (E. coli/HEK293/insect), purity grade, formulation (buffer, carrier-free, glycerol-free), activity/functional validation (binding or enzymatic assays), endotoxin level (low-endotoxin for cell-based work), mutants/variants (point mutations, isoforms), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.

Zhu S, et al. (2025) TLR7/8 signaling activation enhances the potency of human pluripotent stem cell-derived eosinophils in cancer immunotherapy for solid tumors. Exp Hematol Oncol 14:26. 10.1186/s40164-025-00613-y

Zhang Y, et al. (2024) Generation of dual-attribute iTNK cells from hPSCs for cancer immunotherapy. Cell Rep Methods 4:100843. 10.1016/j.crmeth.2024.100843

Xie H, et al. (2022) Transient Inhibition of the JNK Pathway Promotes Human Hematopoietic Stem Cell Quiescence and Engraftment. Stem Cells Transl Med 11:597-603. 10.1093/stcltm/szac019

Guan J, et al. (2022) Chemical reprogramming of human somatic cells to pluripotent stem cells. Nature 605:325-331. 10.1038/s41586-022-04593-5

Xiao X, et al. (2019) Targeting JNK pathway promotes human hematopoietic stem cell expansion. Cell Discov 5:2. 10.1038/s41421-018-0072-8

Matches this product
FREE SAMPLE
Free Sample – MycoFold™ Growth Factors
Limited time offer – availa... Request Free Sample
Matches this product
15% OFF
15% Off Proteins from Trusted Suppliers — Limited Time
Limited Time PT15OFF
$50 OFF
$50 Off All ELISA Kits
Limited time ELISA50
FREE SAMPLE
Free Sample – CellTrypase Recombinant Trypsin-Like Enzyme
Limited time offer – availa... FREESAMPLE

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today